{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Confiance : Questions médicales les plus fréquentes",
"headline": "Confiance : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Confiance : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-22",
"dateModified": "2025-04-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Confiance"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Relations interpersonnelles",
"url": "https://questionsmedicales.fr/mesh/D007398",
"about": {
"@type": "MedicalCondition",
"name": "Relations interpersonnelles",
"code": {
"@type": "MedicalCode",
"code": "D007398",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "F01.829.401"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Confiance",
"alternateName": "Trust",
"code": {
"@type": "MedicalCode",
"code": "D035502",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Peter Fonagy",
"url": "https://questionsmedicales.fr/author/Peter%20Fonagy",
"affiliation": {
"@type": "Organization",
"name": "Anna Freud National Centre for Children and Families, London, United Kingdom."
}
},
{
"@type": "Person",
"name": "H Holden Thorp",
"url": "https://questionsmedicales.fr/author/H%20Holden%20Thorp",
"affiliation": {
"@type": "Organization",
"name": "H. Holden Thorp Editor-in-Chief, Science journals."
}
},
{
"@type": "Person",
"name": "Angelo Cangelosi",
"url": "https://questionsmedicales.fr/author/Angelo%20Cangelosi",
"affiliation": {
"@type": "Organization",
"name": "1 Cognitive Robotics Laboratory, The University of Manchester , Manchester, M13 9PL , UK."
}
},
{
"@type": "Person",
"name": "Jonathan H Marks",
"url": "https://questionsmedicales.fr/author/Jonathan%20H%20Marks",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "An-Sofie Vanhouche",
"url": "https://questionsmedicales.fr/author/An-Sofie%20Vanhouche",
"affiliation": {
"@type": "Organization",
"name": "Postdoctoral Researcher at the Crime and Society Research Group of the Vrije Universiteit Brussel, Belgium. Electronic address: An-Sofie.Vanhouche@vub.be."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Complement factors D and C3 cross-sectionally associate with arterial stiffness, but not independently of metabolic risk factors: The Maastricht Study.",
"datePublished": "2022-07-25",
"url": "https://questionsmedicales.fr/article/35881455",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/HJH.0000000000003237"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cryo-EM structures of Trypanosoma brucei gambiense ISG65 with human complement C3 and C3b and their roles in alternative pathway restriction.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37105991",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41467-023-37988-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elevated complement C3 and increased CD8 and type 1 helper lymphocyte T populations in patients with post-COVID-19 condition.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37453328",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cyto.2023.156295"
}
},
{
"@type": "ScholarlyArticle",
"name": "A novel fasting regimen revealed protein reservation and complement C3 down-regulation after 14-day's continual dietary deprivation.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37484967",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2023.1150547"
}
},
{
"@type": "ScholarlyArticle",
"name": "Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.",
"datePublished": "2023-02-15",
"url": "https://questionsmedicales.fr/article/36805858",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.imbio.2023.152351"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Comportement et mécanismes comportementaux",
"item": "https://questionsmedicales.fr/mesh/D001520"
},
{
"@type": "ListItem",
"position": 3,
"name": "Relations interpersonnelles",
"item": "https://questionsmedicales.fr/mesh/D007398"
},
{
"@type": "ListItem",
"position": 4,
"name": "Confiance",
"item": "https://questionsmedicales.fr/mesh/D035502"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Confiance - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Confiance",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Confiance",
"description": "Comment évaluer la confiance d'un patient ?\nQuels facteurs influencent la confiance des patients ?\nLa confiance affecte-t-elle l'adhésion au traitement ?\nComment mesurer la confiance dans les soins de santé ?\nQuel rôle joue la transparence dans la confiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Complement+C3&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Confiance",
"description": "Quels symptômes indiquent une perte de confiance ?\nComment la méfiance se manifeste-t-elle chez un patient ?\nQuels signes montrent une confiance élevée ?\nLa confiance peut-elle affecter le bien-être psychologique ?\nQuels symptômes psychologiques sont liés à la méfiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Complement+C3&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Confiance",
"description": "Comment prévenir la méfiance envers les médecins ?\nQuel rôle joue l'éducation des patients dans la confiance ?\nComment les politiques de santé influencent-elles la confiance ?\nLes campagnes de sensibilisation peuvent-elles aider ?\nComment la technologie influence-t-elle la confiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Complement+C3&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Confiance",
"description": "Comment améliorer la confiance dans le traitement ?\nLes traitements alternatifs affectent-ils la confiance ?\nComment la confiance influence-t-elle les résultats des traitements ?\nLes effets secondaires affectent-ils la confiance ?\nComment les médecins peuvent-ils renforcer la confiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Complement+C3&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Confiance",
"description": "Quelles complications peuvent résulter d'une faible confiance ?\nComment la méfiance affecte-t-elle les soins préventifs ?\nLes complications psychologiques sont-elles liées à la confiance ?\nComment la confiance influence-t-elle les résultats cliniques ?\nQuelles sont les conséquences d'une mauvaise communication ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Complement+C3&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Confiance",
"description": "Quels facteurs augmentent le risque de méfiance ?\nL'âge influence-t-il la confiance des patients ?\nLes antécédents médicaux affectent-ils la confiance ?\nLe niveau d'éducation influence-t-il la confiance ?\nLes différences culturelles affectent-elles la confiance ?",
"url": "https://questionsmedicales.fr/mesh/D035502?mesh_terms=Complement+C3&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la confiance d'un patient ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires et des entretiens peuvent mesurer la confiance du patient envers le médecin."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent la confiance des patients ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'expérience antérieure, la communication et la réputation du médecin influencent la confiance."
}
},
{
"@type": "Question",
"name": "La confiance affecte-t-elle l'adhésion au traitement ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une confiance élevée augmente l'adhésion aux traitements prescrits par le médecin."
}
},
{
"@type": "Question",
"name": "Comment mesurer la confiance dans les soins de santé ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échelles de mesure et des enquêtes peuvent évaluer la confiance dans les soins de santé."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la transparence dans la confiance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transparence des informations médicales renforce la confiance entre le patient et le médecin."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une perte de confiance ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété, la méfiance et la réticence à poser des questions peuvent signaler une perte de confiance."
}
},
{
"@type": "Question",
"name": "Comment la méfiance se manifeste-t-elle chez un patient ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méfiance peut se manifester par des doutes sur les diagnostics ou les traitements proposés."
}
},
{
"@type": "Question",
"name": "Quels signes montrent une confiance élevée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un patient qui pose des questions et suit les recommandations montre une confiance élevée."
}
},
{
"@type": "Question",
"name": "La confiance peut-elle affecter le bien-être psychologique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une faible confiance peut entraîner du stress et affecter le bien-être psychologique."
}
},
{
"@type": "Question",
"name": "Quels symptômes psychologiques sont liés à la méfiance ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méfiance peut entraîner des symptômes comme la dépression et l'anxiété chez les patients."
}
},
{
"@type": "Question",
"name": "Comment prévenir la méfiance envers les médecins ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La formation continue des médecins et la transparence des soins peuvent prévenir la méfiance."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'éducation des patients dans la confiance ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation des patients sur leur santé renforce leur confiance envers les professionnels de santé."
}
},
{
"@type": "Question",
"name": "Comment les politiques de santé influencent-elles la confiance ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des politiques de santé transparentes et éthiques renforcent la confiance du public dans le système de santé."
}
},
{
"@type": "Question",
"name": "Les campagnes de sensibilisation peuvent-elles aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les campagnes de sensibilisation sur la santé renforcent la confiance des patients dans les soins."
}
},
{
"@type": "Question",
"name": "Comment la technologie influence-t-elle la confiance ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "La technologie peut renforcer la confiance par l'accès à l'information et la communication améliorée."
}
},
{
"@type": "Question",
"name": "Comment améliorer la confiance dans le traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une communication claire et des explications détaillées peuvent améliorer la confiance dans le traitement."
}
},
{
"@type": "Question",
"name": "Les traitements alternatifs affectent-ils la confiance ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de traitements alternatifs peut diminuer la confiance dans les soins conventionnels."
}
},
{
"@type": "Question",
"name": "Comment la confiance influence-t-elle les résultats des traitements ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une confiance élevée peut améliorer l'efficacité des traitements et la satisfaction des patients."
}
},
{
"@type": "Question",
"name": "Les effets secondaires affectent-ils la confiance ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les effets secondaires peuvent diminuer la confiance des patients dans le traitement prescrit."
}
},
{
"@type": "Question",
"name": "Comment les médecins peuvent-ils renforcer la confiance ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les médecins peuvent renforcer la confiance par l'écoute active et la validation des préoccupations des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent résulter d'une faible confiance ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une faible confiance peut entraîner une mauvaise adhésion aux traitements et des complications de santé."
}
},
{
"@type": "Question",
"name": "Comment la méfiance affecte-t-elle les soins préventifs ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La méfiance peut réduire l'utilisation des soins préventifs, augmentant le risque de maladies."
}
},
{
"@type": "Question",
"name": "Les complications psychologiques sont-elles liées à la confiance ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une faible confiance peut entraîner des complications psychologiques comme l'anxiété et la dépression."
}
},
{
"@type": "Question",
"name": "Comment la confiance influence-t-elle les résultats cliniques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une confiance élevée est associée à de meilleurs résultats cliniques et à une satisfaction accrue."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une mauvaise communication ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une mauvaise communication peut entraîner des malentendus et diminuer la confiance entre patient et médecin."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de méfiance ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des expériences négatives antérieures et un manque de communication augmentent le risque de méfiance."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la confiance des patients ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients plus âgés peuvent avoir des niveaux de confiance différents en fonction de leurs expériences."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux affectent-ils la confiance ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de soins insatisfaisants peuvent diminuer la confiance dans les soins futurs."
}
},
{
"@type": "Question",
"name": "Le niveau d'éducation influence-t-il la confiance ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un niveau d'éducation plus élevé est souvent associé à une meilleure compréhension et confiance."
}
},
{
"@type": "Question",
"name": "Les différences culturelles affectent-elles la confiance ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les différences culturelles peuvent influencer la perception de la confiance dans les soins de santé."
}
}
]
}
]
}
Arterial stiffness predicts cardiovascular outcomes. The complement system, particularly the alternative complement pathway, has been implicated in cardiovascular diseases. We herein investigated the ...
In 3019 population-based participants (51.9% men, 60.1 ± 8.2 years, 27.7% type 2 diabetes [T2D], oversampled]), we measured carotid-femoral pulse wave velocity (cfPWV), carotid distensibility coeffici...
Per SD higher factors D and C3, cfPWV was 0.41 m/s [95% confidence interval: 0.34; 0.49] and 0.33 m/s [0.25; 0.41] greater, respectively. These associations were substantially attenuated when adjusted...
The strong association of plasma factors D and C3 with arterial stiffness in this population-based cohort was not independent of T2D and other metabolic risk factors. Our data suggest that a possible ...
African Trypanosomes have developed elaborate mechanisms to escape the adaptive immune response, but little is known about complement evasion particularly at the early stage of infection. Here we show...
Biological markers associated to post-COVID-19 condition (PCC) have not been clearly identified....
Eighty-two patients attending our post-COVID-19 outpatient clinic were recruited and classified as fully recovered (40.2%) or presenting with PCC (59.8%). Clinical and radiological data, laboratory ma...
Median number of days after hospitalization was 78.5 [p25-p75: 60-93] days. PCC was significantly more frequent in women, in patients with a previously critical COVID-19, and in those with two or more...
Patients with a post-COVID-19 condition showed significantly increased immunological parameters of inflammation (complement factor C3 and CD8 and Th1 T lymphocyte populations) compared to fully recove...
The aim is to evaluate the effect of a novel 14-day fasting regimen on the balance between skeletal muscle and adipose tissue composition which might associate with inflammatory factors. Our analysis ...
Eight healthy subjects were randomly selected from a pool of volunteers to undergo a continual dietary deprivation (CDD) regimen. Individuals were assigned to take Flexible Abrosia (FA, prebiotic comb...
The combination of FA and mineral supplements significantly decreased self-reported physical response of starvation, with tolerable hunger-mediated sensations experienced during CDD. Bioelectrical and...
Our results indicated that human subjects undergoing prolonged dietary restriction were well protected by FA and mineral ions from gut injury or physical discomfort of starvation. Most factors showed ...
We have attempted to explore further the involvement of complement components in the host COVID-19 (Coronavirus disease-19) immune responses by targeted genotyping of COVID-19 adult patients and analy...
Recently, it was shown that children at the onset of type 1 diabetes (T1D) have a higher proportion of oligomannose glycans in their total plasma protein N-glycome compared to their healthy siblings. ...
Patients with chronic hepatitis B (CHB) have a dynamic disease process and risk of end-stage liver disease. It is critical to unambiguously differentiate the stages of the disease and focus on therapy...
We retrospectively analyzed a wide range of CHB patients at different stages. The predictive power of serum complement component 3 (C3) levels for the development of acute-on-chronic liver failure (AC...
The decrease in serum C3 levels paralleled the severity of diseases related to hepatitis B virus. Patients with decompensated cirrhosis who developed ACLF had significantly lower serum C3 levels than ...
Serum C3 levels are valuable in assessing the severity of CHB-related stages. Low C3 levels signifies the development of ACLF in patients with decompensated cirrhosis....
A 62-year-old man with nephritic syndrome underwent a kidney biopsy which revealed a C3 dominant pattern on immunofluorescence. A diagnosis of C3 glomerulopathy (C3G) was suspected. However, a recent ...
C3 glomerulopathy (C3G) is a rare, progressive kidney disease resulting from dysregulation of the alternative pathway (AP) of complement. Biomarkers at baseline were investigated in patients with C3G ...
Patients with biopsy-confirmed C3G, proteinuria ≥500 mg/day, and estimated glomerular filtration rate (eGFR) ≥30 mL/min/1.73 m2 were enrolled into two studies (NCT03369236 and NCT03459443). Biomarker ...
Twenty-nine patients were included in the analysis (median [interquartile range] age: 24.0 [10.0] years). Systemic complement AP activation was evident by reduced median concentrations of C3 and C5, e...
Associations among complement biomarkers, kidney function, and kidney histology may add to the current understanding of C3G and assist with the characterization of patients with this heterogenous dise...
Antibodies against Rho GDP-dissociation inhibitor 2 (RhoGDI2) are associated with inferior graft survival in transplant patients receiving a kidney from deceased donors. Although this suggests that th...